These results call into question the JNC 8 panel recommendation to relaxsystolic BP targets to <150 mm Hg for patients aged 60 and older, according to the researchers.
Ischaemic preconditioning has well-established cardiac and vascular protective effects. Short interventions (one week) of daily ischaemic preconditioning episodes improve conduit and microcirculatory function.
The FDA has approved the oral anticoagulant drug apixaban for treating deep vein thrombosis and pulmonary embolism and for preventing recurrent episodes of these conditions, according to the two firms selling the drug.
Scientific programme endorsed by the European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a registered branch of the European Society of Cardiology (ESC).
The incidence of sick sinus syndrome in the United States is projected to double in the next 50 years, with increased risk specifically in older and white adults.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.